Skip to content

BLIS - Breastfeeding Levonorgestrel IUD Study

Randomized Controlled Trial of Early Versus Standard Postpartum Insertion of the Levonorgestrel IUD to Assess Breast Feeding Outcomes (BLIS - Breastfeeding Levonorgestrel IUD Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01990703
Acronym
BLIS
Enrollment
285
Registered
2013-11-21
Start date
2014-01-31
Completion date
2017-01-31
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Contraception, Birth Control, Levonorgestrel IUD, Mirena IUD

Brief summary

We are studying the effect of placing the levonorgestrel IUD (Mirena) immediately after birth on breastfeeding. Women who wish to have a levonorgestrel IUD placed after their birth, wish to breastfeed, and are willing to participate in the study will be randomly assigned to either get the IUD placed immediately after delivery of the baby and placenta or 4-6 weeks later. We do not believe there will be a difference in breastfeeding 8 weeks after delivery between those who get the IUD placed early or later.

Detailed description

Increasing use of the levonorgestrel intrauterine device (LNG IUD) has become a cornerstone of U.S. efforts to decrease our nation's high rate of unplanned pregnancy. Many women initiate use of this method in the post partum period. The major advantage of immediate postplacental LNG IUD insertion is the prompt initiation of a highly effective contraceptive method at a time that does not interfere with the intense demands of newborn care, but any contraceptive method initiated in the postpartum period must not interfere with breastfeeding. Our long-term goal is to understand the impact of hormonal contraceptives, initiated early in the postpartum period, on breastfeeding. The central hypothesis is that quality of breastfeeding is not negatively affected by progestin-only hormonal contraceptives. We will pursue three specific aims comparing women randomized to immediate post-placental vs. delayed (4-6 week) postpartum LNG IUD insertion: Aim #1: To determine breastfeeding continuation rates at 8 weeks in both groups Aim #2: To determine timing of lactogenesis in both groups Aim #3: To assess breastfeeding continuation, exclusivity, and satisfaction as well as continuation and satisfaction with the LNG IUD at 26 weeks postpartum in both groups This proposal will support a non-inferiority RCT where participants will be randomly assigned to immediate postplacental insertion (within 10 minutes of placental delivery) or delayed postpartum insertion (4-6 weeks postpartum). This project will provide needed evidence on breastfeeding impact of early postpartum initiation of the LNG IUD.

Interventions

Timing of IUD insertion

Sponsors

Society of Family Planning
CollaboratorOTHER
University of New Mexico
CollaboratorOTHER
University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Healthy, 18-40 year old pregnant women * Intend to breastfeed * Desire the LNG IUD as their method of contraception * Agree to be randomized to early versus standard postpartum insertion * Have delivered a healthy term infant (37 weeks gestation) * Willing to complete all study related procedures, visits and questionnaires

Exclusion criteria

* Chorioamnionitis * Obstetric complications including transfusion * Severe pregnancy induced hypertension * Prolonged hospitalization * Coagulopathy * Liver disease * Undiagnosed genital bleeding, or other relative contraindication to LNG IUD insertion (known or suspected pregnancy, uterine cavity abnormality, known, suspected, or history of breast cancer, or hypersensitivity to any of the components in the LNG IUD).

Design outcomes

Primary

MeasureTime frameDescription
Breastfeeding Continuation Rates at 8 Weeks Postpartum8 weeks postpartumTo determine breastfeeding continuation rates at 8 weeks in women randomized to immediate post-placental vs. delayed (4-8 weeks) postpartum levonorgestrel IUD insertion.

Secondary

MeasureTime frameDescription
Time to Lactogenesis Stage 2First 5 days after birthTo evaluate potential delay in lactogenesis caused by immediate postpartum insertion of the LNG IUD.

Countries

United States

Participant flow

Participants by arm

ArmCount
Early IUD Insertion Group
Immediate post-placental placement of the levonorgestrel IUD Levonorgestrel IUD: Timing of IUD insertion
147
Standard Postpartum Insertion Group
Placement of the levonorgestrel IUD 4-6 weeks postpartum Levonorgestrel IUD: Timing of IUD insertion
138
Total285

Baseline characteristics

CharacteristicStandard Postpartum Insertion GroupEarly IUD Insertion GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
138 Participants147 Participants285 Participants
Age, Continuous28.1 Years
STANDARD_DEVIATION 5.6
28.6 Years
STANDARD_DEVIATION 5.4
28.4 Years
STANDARD_DEVIATION 5.5
Region of Enrollment
United States
138 participants147 participants285 participants
Sex: Female, Male
Female
138 Participants147 Participants285 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 1470 / 138
serious
Total, serious adverse events
1 / 1470 / 138

Outcome results

Primary

Breastfeeding Continuation Rates at 8 Weeks Postpartum

To determine breastfeeding continuation rates at 8 weeks in women randomized to immediate post-placental vs. delayed (4-8 weeks) postpartum levonorgestrel IUD insertion.

Time frame: 8 weeks postpartum

Population: 147 Early IUD Insertion participants at baseline drops to 112 at 8 weeks due to exclusions for medical complications (n=15), inability to provide immediate IUD (n=7) and loss to follow up (n=13). In the Standard Insertion group 138 at baseline drops to 102 at 8 weeks with medical comps (n=11), failure to receive IUD (n=24), and 1 loss to follow up.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Early IUD Insertion GroupBreastfeeding Continuation Rates at 8 Weeks Postpartum88 Participants
Standard Postpartum Insertion GroupBreastfeeding Continuation Rates at 8 Weeks Postpartum86 Participants
Secondary

Time to Lactogenesis Stage 2

To evaluate potential delay in lactogenesis caused by immediate postpartum insertion of the LNG IUD.

Time frame: First 5 days after birth

ArmMeasureValue (MEAN)Dispersion
Early IUD Insertion GroupTime to Lactogenesis Stage 265.3 HoursStandard Deviation 25.7
Standard Postpartum Insertion GroupTime to Lactogenesis Stage 263.6 HoursStandard Deviation 21.6

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026